C07C251/20

GADUSOL-CONTAINING SUNSCREEN FORMULATIONS

Embodiments of sunscreen formulations are disclosed herein. In one example, a sunscreen formulation includes a) a physical/inorganic sunscreen active ingredient at from about 5% to about 25% on a weight/weight (w/w) basis, wherein the active ingredient generates a first sun protection factor (“SPF”) value to a sunscreen formulation; b) gadusol; and c) a plurality of ingredients configured to deliver ingredients a) and b) in the sunscreen formulation, wherein the gadusol is present in the sunscreen formulation in an amount sufficient to generate a SPF booster effect in the sunscreen formulation.

ANALOGUES OF MYCOSPORINE-LIKE AMINO ACID AND USE THEREOF AS SUNSCREENS

The present invention relates to compounds of formula (I) as defined herein. The compounds are suitable for protection against ultraviolet (UV) radiation. Further, the present invention is concerned with compositions comprising at least one compound of formula (I).

##STR00001##

GADUSOL-CONTAINING SUNSCREEN FORMULATIONS

Embodiments of sunscreen formulations are disclosed herein. In one example, a sunscreen formulation includes a) a physical/inorganic sunscreen active ingredient at from about 5% to about 25% on a weight/weight (w/w) basis, wherein the physical/inorganic sunscreen active ingredient generates a first sun protection factor (“SPF”) value to a sunscreen formulation; b) gadusol; and c) a plurality of ingredients configured to deliver ingredients a) and b) in the sunscreen formulation, wherein the gadusol is present in the sunscreen formulation in an amount sufficient to generate a SPF booster effect in the sunscreen formulation to provide an enhanced SPF value for the sunscreen formulation that is at least 1.5 times the first SPF value generated by the physical/inorganic sunscreen active ingredient when the physical/inorganic sunscreen active ingredient is present at a same amount in a formulation that does not contain gadusol.

SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX

Compositions and methods for treating thrombosis, inflammation, and atherosclerosis by administration of a compound that binds to KRIT1 to inhibit binding with HEG1.

COMPOUNDS AND MIXTURES WITH ANTIDEGRADANT AND ANTIFATIGUE EFFICACY AND COMPOSITIONS INLUDING SUCH COMPOUNDS

Antidegradant compounds are disclosed, and methods of making them, that are represented by the formula I:

##STR00001## wherein each X is independently selected from the group consisting of ethyl, methyl, or hydrogen.

Also disclosed are diimine intermediates corresponding to formula III:

##STR00002## wherein each X is independently selected from the group consisting of ethyl, methyl, or hydrogen. These intermediates themselves exhibit antidegradant activity.

COMPOUNDS AND MIXTURES WITH ANTIDEGRADANT AND ANTIFATIGUE EFFICACY AND COMPOSITIONS INLUDING SUCH COMPOUNDS

Antidegradant compounds are disclosed, and methods of making them, that are represented by the formula I:

##STR00001## wherein each X is independently selected from the group consisting of ethyl, methyl, or hydrogen.

Also disclosed are diimine intermediates corresponding to formula III:

##STR00002## wherein each X is independently selected from the group consisting of ethyl, methyl, or hydrogen. These intermediates themselves exhibit antidegradant activity.

COMPOUNDS AND MIXTURES WITH ANTIDEGRADANT AND ANTIFATIGUE EFFICACY AND COMPOSITIONS INLUDING SUCH COMPOUNDS

Antidegradant compounds are disclosed, and methods of making them, that are represented by the formula I:

##STR00001## wherein each X is independently selected from the group consisting of ethyl, methyl, or hydrogen.

Also disclosed are diimine intermediates corresponding to formula III:

##STR00002## wherein each X is independently selected from the group consisting of ethyl, methyl, or hydrogen. These intermediates themselves exhibit antidegradant activity.

PRODUCTION PROMOTER OF TYPE I COLLAGEN OR ELASTIN
20220168253 · 2022-06-02 · ·

A type I collagen or elastin production promoter containing a mycosporine-like amino acid or a salt thereof as an active ingredient; and a method for promoting type I collagen or elastin production, the method including administering an effective amount of a mycosporine-like amino acid or a salt thereof.

RESIN COMPOSITION, COATED AND DRIED PRODUCT, MELT-KNEADED PRODUCT, OPTICAL FILTER, IMAGE DISPLAY DEVICE, SOLID-STATE IMAGING ELEMENT, SQUARYLIUM COMPOUND, AND METHOD FOR PRODUCING THE SAME

Provided are a resin composition containing a squarylium compound and a resin, in which the squarylium compound includes at least one selected from squarylium compounds represented by specific formulae; a coated and dried product or a melt-kneaded product; an optical filter including these components; an image display device and a solid-state imaging element including the optical filter; and a squarylium compound represented by a specific formula and a method for producing the same.

COMPOSITION FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND
20230280655 · 2023-09-07 · ·

A composition for forming an organic film, including: a compound represented by the following general formula (1); and an organic solvent, wherein in the general formula (1), X represents any one group of X1 to X3 represented by the following general formulae (2), (3), and (5), and two or more kinds of X are optionally used in combination, wherein in the general formula (3), W represents a carbon atom or a nitrogen atom; “n1” represents 0 or 1; “n2” represents an integer of 1 to 3; and R.sub.1 independently represents any one of groups represented by the following general formula (4), and wherein in the general formula (5), R.sub.2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms; and R.sub.3 represents any one of the following groups.

##STR00001## ##STR00002##